Roche Holding AG (TSX:ROG)

Market Cap	433.98B
Revenue (ttm)	108.88B
Net Income (ttm)	16.17B
Shares Out	n/a
EPS (ttm)	20.14
PE Ratio	26.84
Forward PE	15.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	930
Average Volume	11,206
Open	22.86
Previous Close	23.12
Day's Range	22.84 - 22.89
52-Week Range	18.42 - 24.40
Beta	n/a
RSI	62.88
Earnings Date	Oct 27, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Other
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ROG

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF